Navigation Links
Ambry Genetics Introduces AmbryScreen(TM), a Genetic Test Screening for Some of the Most Common and Severe Genetic Disorders Affecting Newborns.
Date:5/17/2010

SAN FRANCISCO, May 17 /PRNewswire/ -- Ambry Genetics announced today at the American College of Obstetricians and Gynecologists annual clinical meeting the launch of AmbryScreen™, a genetic screening test used to identify carriers of some of the most severe and common childhood diseases affecting pan-ethnic populations.  Designed by a team of geneticists and genetic counselors with decades of clinical and laboratory experience, the panel is a responsible and ethical means of identifying individuals at high risks to have a child with severe genetic conditions.  As with all clinical assays performed by Ambry Genetics, the test must be ordered by a physician.  It is not available direct to consumer.

(Logo:  http://photos.prnewswire.com/prnh/20090428/LA06744LOGO)

The AmbryScreen™ test screens for over 90 childhood onset conditions representing only severe or common diseases. The core of the AmbryScreen™ test is the most sensitive Cystic Fibrosis carrier mutation panel in the marketplace.  It was designed by coupling the public databases of information along with Ambry's extensive database of over 25,000 patients sequenced in the last decade.  Our 100 CF mutation panel includes only well defined disease causing mutations, without containing mild CF mutations like some competing tests.  

"Ambry Genetics was founded on the idea of a comprehensive carrier test and now new technologies have enabled us to create a test that makes sense for patients and for physicians.  When we saw other companies launch seriously flawed tests, the team of Ambry genetic counselors set out to design a superior test.  Our collective decades of experience and real world clinical knowledge created what we think is the best carrier screening test available on the market today," said Steven Keiles, VP and Director of Genetic Services.

"Ambry Genetics is very well suited to offer this type of test.  We have been working with the Ob/Gyn community on complicated genetic situations for a decade, and we have a staff of counselors and geneticists to work with physicians and their staff on these types of products," said Charles Dunlop, Chief Executive Officer of Ambry Genetics.  

"With more direct to consumer type tests coming online, we want to clearly differentiate ourselves from those laboratories.  We have the experience, the compliance to regulatory guidelines and laws, and the professional staff and expertise to handle these types of tests adequately," said Taosheng Huang MD, PhD, FACMG, Medical Director

About Ambry Genetics Ambry Genetics is a CAP-accredited and CLIA-certified commercial clinical laboratory headquartered in Aliso Viejo, California. Since the company's inception in 2000, it has become a leader in providing genetic services focused on clinical diagnostics and genomic services. Ambry has built a solid reputation for unparalleled service, and has been at the forefront of applying new technologies to the clinical molecular diagnostics market and advancements in disease research. To learn more about testing and services available through Ambry, visit www.ambrygen.com.


'/>"/>
SOURCE Ambry Genetics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
2. Ambry Genetics Announces Launch of Their StemArray(TM) Product and Services for High Resolution Characterization of Human Stem Cells
3. Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects
4. London Genetics Conference Proceedings Published in Drug Discovery Today
5. Interleukin Genetics, Inc. Announces Conference Call to Discuss First Quarter 2010 Results
6. NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards
7. Interleukin Genetics to Raise $5.3 Million in Registered Direct Offering
8. First Awards Made by London Genetics Proof-of-Concept Fund
9. Viral Genetics CEO Issues State of the Company Update
10. Expanded London Genetics Web Site Emphasises Importance of Pharmacogenetics in Drug Development
11. Viral Genetics Files 2009 3rd Quarter Consolidated Financials and Information Statement at Pinksheets.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):